97.46USD-6.12%Mkt Cap: 1.44B USDP/E: —Last update: 2026-06-01
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.44B USD
Enterprise Value1.55B USD
Revenue (TTM)1.30M USD
Gross Profit-100.07M USD
Net Income (TTM)-140.06M USD
Revenue/Share0.0840 USD
Last Price97.46 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees109
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-37.28
PEG—
EV/EBITDA-12.80
EV/Revenue1188.61
P/S1173.81
P/B189.80
EPS (TTM)-8.39
EPS (Forward)-2.79
52W Range
12.7259% of range155.29
52W High155.29 USD
52W Low12.72 USD
Profitability
Gross Margin0.00%
Oper. Margin-9465.46%
EBITDA Margin0.00%
Profit Margin-10773.46%
ROE-1752.22%
ROA-95.62%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-129.79M USD
CapEx (TTM)31.00K USD
FCF Margin-6854.45%
FCF Yield-6.17%
Net Debt19.24M USD
Net Debt/EBITDA-0.16
Balance Sheet
Debt/Equity13.39
Current Ratio6.46
Quick Ratio6.11
Book Value/Sh0.5480 USD
Cash/Share11.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)277.50 USD
Target Range230.00 USD – 325.00 USD
# Analysts2
Ownership
Shares Out.14.67M
Float7.86M
Insiders23.16%
Institutions83.00%
Short Interest
Short Ratio4.4d
Short % Float26.72%
Short % Out.19.99%
Shares Short2.93M
Short (prev mo.)2.14M
Technical
SMA 5095.85 (+1.7%)
SMA 20069.95 (+39.3%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)582.34K
Avg Vol (10d)381.33K
Technical Indicators
RSI (14)47.0
MACD-0.2318
MACD Signal2.8389
MACD Hist.-3.0707
BB Upper140.28 USD
BB Middle115.77 USD
BB Lower91.26 USD
BB Width42.34%
ATR (14)10.50 USD
Vol Ratio (20d)0.28x